Literature DB >> 24414182

Infective endocarditis initially presenting with a dermatomyositis-like syndrome.

Joel Ojeda1, Linnette López-López, Anarda González, Luis M Vilá.   

Abstract

Infective endocarditis (IE) may present with rheumatological manifestations such as myalgias, arthralgias, arthritis and back pain. However, muscle inflammation is rare. We present a case of a 68-year-old Hispanic man who presented with 1-month history of tiredness, weight loss, fever, myalgias, muscle weakness and dysphagia to solid food. On physical examination he had severe weakness in the proximal upper and lower extremities, and erythematous eruption involving the upper eyelids, neck and metacarpophalangeal joints. Creatine kinase levels were markedly elevated at 15 809 U/L. MRI of the right thigh revealed intermuscular and intramuscular oedema. Muscle biopsy showed acute necrotising suppurative perimyositis. Blood cultures were positive for methicillin-resistant Staphylococcus aureus. A transoesophageal echocardiogram revealed vegetations in the pulmonic valve. All clinical manifestations were resolved completely with broad-spectrum antibiotics. This case suggests that IE should be considered in the differential diagnosis of a patient presenting with inflammatory myopathy.

Entities:  

Mesh:

Year:  2014        PMID: 24414182      PMCID: PMC3902320          DOI: 10.1136/bcr-2013-200865

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

Review 1.  Infective endocarditis in adults.

Authors:  E Mylonakis; S B Calderwood
Journal:  N Engl J Med       Date:  2001-11-01       Impact factor: 91.245

2.  Rheumatic manifestations of infective endocarditis in non-addicts. A 12-year study.

Authors:  C González-Juanatey; M A González-Gay; J Llorca; F Crespo; C García-Porrúa; J Corredoira; J Vidán; J R González-Juanatey
Journal:  Medicine (Baltimore)       Date:  2001-01       Impact factor: 1.889

3.  Infections in polymyositis and dermatomyositis: analysis of 192 cases.

Authors:  I-Jung Chen; Wen-Pin Tsai; Yeong-Jian Jan Wu; Shue-Fen Luo; Huei-Huang Ho; Lieh-Bang Liou; Ji-Yih Chen; Chang-Fu Kuo; Hsiao-Chun Chang; Chung-Han Yang; Kuang-Hui Yu
Journal:  Rheumatology (Oxford)       Date:  2010-09-13       Impact factor: 7.580

4.  Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980-1995.

Authors:  R O Netzer; E Zollinger; C Seiler; A Cerny
Journal:  Heart       Date:  2000-07       Impact factor: 5.994

5.  Rheumatological manifestations of infective endocarditis.

Authors:  P Thomas; J Allal; D Bontoux; F Rossi; J Y Poupet; J P Petitalot; B Becq-Giraudon
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

6.  Circulating immune complexes in infective endocarditis.

Authors:  A S Bayer; A N Theofilopoulos; R Eisenberg; F J Dixon; L B Guze
Journal:  N Engl J Med       Date:  1976-12-30       Impact factor: 91.245

7.  Musculoskeletal manifestations of bacterial endocarditis.

Authors:  Y Levo; M Nashif
Journal:  Clin Exp Rheumatol       Date:  1983 Jan-Mar       Impact factor: 4.473

8.  Use of circulating immune complex levels in the serodifferentiation of endocarditic and nonendocarditic septicemias.

Authors:  A S Bayer; A N Theofilopoulos; D B Tillman; F J Dixon; L B Guze
Journal:  Am J Med       Date:  1979-01       Impact factor: 4.965

9.  Nature of circulating immune complexes in infective endocarditis.

Authors:  J Burton-Kee; P Morgan-Capner; J F Mowbray
Journal:  J Clin Pathol       Date:  1980-07       Impact factor: 3.411

10.  Musculoskeletal manifestations of bacterial endocarditis.

Authors:  O L Meyers; P J Commerford
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

View more
  1 in total

Review 1.  Fatal endocarditis with methicilin-sensible Staphylococcus aureus and major complications: rhabdomyolysis, pericarditis, and intracerebral hematoma: A case report and review of the literature.

Authors:  Anca Meda Georgescu; Leonard Azamfirei; Krisztina Szalman; Edit Szekely
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.